• OBARPHYLLINE SR 12 - 150 mg is a bronchodilator belonging to the methylxanthine class, used to treat a range of respiratory disorders.
• OBARPHYLLINE SR 12 - 150 mg is an important option for treating patients with reversible airflow obstruction and helps improve the quality of life for these patients.
• OBARPHYLLINE SR 12 - 150 mg capsules are characterized by their extended-release formulation, which allows for slow release into the bloodstream and maintains a stable level of the active ingredient in circulation. This contributes to a reduction in asthma attacks and other respiratory symptoms throughout the day, while also minimizing the side effects associated with the active ingredient.

Each OBARPHYLLINE SR 12 - 150 mg capsule contains 150 mg theophylline anhydrous.

Adults:

OBARPHYLLINE SR 12 - 150 mg is indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis.

Children:

OBARPHYLLINE SR 12 - 150 mg are not indicated for use in children under 2 years of age.

Pregnancy& breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking OBARPHYLLINE SR 12 - 150 mg.

There are no adequate and well-controlled studies in pregnant women. Theophylline should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Pregnancy Category: C.

OBARPHYLLINE SR 12 - 150 mg should not be used whilst breastfeeding because OBARPHYLLINE SR 12 - 150 mg may cause irritability or other signs of mild toxicity in nursing human infants.

Adults (16 years of age to 59 years of age who weigh more than 45 kg):

The recommended dose of OBARPHYLLINE SR 12 - 150 mg capsules is 2 capsules (200 mg) every 12 hours.

Children

The recommended dose of OBARPHYLLINE SR 12 - 150 mg capsules is:

• 2 years of age to 6 years of age: 60 mg - 120 mg twice daily.
• 6 years of age to 12 years of age: 125 mg - 250 mg twice daily.
• 12 years of age to 16 years of age: 250 mg - 500 mg twice daily.